Mastopatia fibroquistica

Solo disponible en BuenasTareas
  • Páginas : 20 (4828 palabras )
  • Descarga(s) : 0
  • Publicado : 5 de marzo de 2012
Leer documento completo
Vista previa del texto
Note: This copy is for your personal non-commercial use only. To order presentation-ready copies for distribution to your colleagues or clients, contact us at www.rsna.org/rsnarights.

APPLICATIONS OF CURRENT TECHNOLOGY

S53

Complex Cystic Breast Masses: Diagnostic Approach and ImagingPathologic Correlation1
CME FEATURE
See accompanying test at http:// www.rsna.org /education/rg_cme.html

Devang J. Doshi, MD ● David E. March, MD ● Giovanna M. Crisi, MD, PhD ● Bret F. Coughlin, MD Complex cystic breast masses demonstrate both anechoic (cystic) and echogenic (solid) components at ultrasonography (US). US is used to identify and characterize such masses and to guide percutaneous biopsy. Numerous pathologic entities may produce complex cystic breast lesions or may be associatedwith them, and biopsy is usually indicated. Common benign findings include fibrocystic changes, intraductal or intracystic papilloma without atypia, and fibroadenoma. Common atypical findings include atypical ductal hyperplasia, atypical papilloma, atypical lobular hyperplasia, and lobular carcinoma in situ. Malignant findings include ductal carcinoma in situ, infiltrating ductal carcinoma, andinfiltrating lobular carcinoma. If the biopsy approach is tailored to the individual patient and if the imaging features are closely correlated with findings at pathologic analysis, US-guided percutaneous biopsy may be used effectively to diagnose and to guide management of complex cystic masses.
©

LEARNING OBJECTIVES FOR TEST 2
After reading this article and taking the test, the reader will be able to:Recognize the imaging features of complex cystic breast masses. Describe current biopsy techniques used to diagnose complex cystic breast masses. Identify the common pathologic diagnoses of complex cysts in the breast.

RSNA, 2007

TEACHING POINTS See last page

Abbreviations: DCIS

ductal carcinoma in situ, H-E

hematoxylin-eosin

RadioGraphics 2007; 27:S53–S64 ● Published online10.1148/rg.27si075508 ● Content Codes:
1From

the Departments of Radiology (D.J.D., D.E.M., B.F.C.) and Pathology (G.M.C.), Baystate Medical Center–The Western Campus of Tufts University School of Medicine, 759 Chestnut St, Springfield, MA 01199. Recipient of a Certificate of Merit award for an education exhibit at the 2006 RSNA Annual Meeting. Received February 21, 2007; revision requested April 2 andreceived April 23; accepted May 3. All authors have no financial relationships to disclose. Address correspondence to D.J.D. (e-mail: djdoshi12@yahoo.com). RSNA, 2007

©

S54

October 2007

RG f Volume 27



Special Issue

Introduction
Cystic breast lesions are commonly observed at ultrasonography (US) performed for the evaluation of palpable or mammographically detected breastmasses. Complex cysts contain cystic and solid components and are associated with a variety of benign, atypical, and malignant pathologic diagnoses. Complex cystic breast masses have a substantial chance of being malignant; malignancy was reported in 23% (1) and 31% (2) of cases in two series. For that reason, percutaneous or surgical biopsy is usually indicated. Techniques that may be used forsampling of complex cystic breast masses include fine-needle aspiration, core-needle biopsy (with an automated spring-loaded or vacuum-assisted device), and surgical excision. This article reviews the imaging evaluation of complex cystic breast masses, various approaches to percutaneous biopsy, and common pathologic diagnoses.

Teaching Point

Imaging Evaluation
Mammography
Many patients withcomplex cystic masses have undergone recent mammography, which may help characterize the mass, depict associated microcalcifications (Fig 1), and show additional suspicious lesions (3). If a lesion appears fat-containing at mammography, it represents a benign entity such as an oil cyst or galactocele, and biopsy can be avoided. For lesions that are proved malignant at biopsy, mammography may...
tracking img